ALEXANDRIA, Va., June 25 -- United States Patent no. 12,338,292, issued on June 24, was assigned to IGI Therapeutics SA (La Chaux-de-Fonds, Switzerland).
"CD47-CD38 bispecific antibodies" was invented by Laure Bouchez (La Chaux-de-Fonds, Switzerland), Blandine Pouleau (La Chaux-de-Fonds, Switzerland), Marie-Agnes Doucey (La Chaux-de-Fonds, Switzerland), Elie Dheilly (La Chaux-de-Fonds, Switzerland), Stanislas Blein (La Chaux-de-Fonds, Switzerland), Cian Stutz (La Chaux-de-Fonds, Switzerland), Carole Estoppey (La Chaux-de-Fonds, Switzerland), Jeremy Loyau (La Chaux-de-Fonds, Switzerland), Thierry Monney (La Chaux-de-Fonds, Switzerland), Camille Grandclement (La Chaux-de-Fonds, Switzerland) and Stefano Sammicheli (La Chaux-de-Fonds, Switzerl...